Background and Objective: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the mucociliary system, leading to progressive lung damage. This deterioration can result in bronchiectasis, atelectasis, and respiratory failure, necessitating lung transplantation in severe cases. This study aims to assess ciliary motility and ultrastructure in the bronchial epithelium of transplanted lungs in patients with PCD to determine whether mucociliary function is preserved post-transplantation. The findings seek to enhance scientific understanding and provide prognostic insights for these patients. Materials and Methods: A prospective observational study was conducted on two patients with PCD and advanced lung disease who underwent bilateral lung transplantation. Nasal and bronchial cilia samples were analyzed using high-speed videomicroscopy and transmission electron microscopy. Follow-up assessments included ciliary function analysis, lung rejection monitoring, and quality-of-life evaluations, with follow-up extending up to 30 months post-transplant. Results: Post-transplant evaluations demonstrated normal ciliary motility and ultrastructure in the transplanted lungs throughout the study period (up to 30 months), indicating the long-term preservation of mucociliary function. Conclusions: Transplanted lungs in patients with PCD maintain normal bronchial ciliary motility and structure in the long term, suggesting a favorable prognosis for both the graft and the recipient. These findings support the feasibility and long-term effectiveness of lung transplantation in patients with PCD.
12 July 2025 in European Archives of Oto-Rhino-Laryngology
Purpose: Odontogenic sinusitis (ODS) is a frequent but underdiagnosed condition requiring multidisciplinary management. This study aims to compare outcomes between single-stage combined surgical treatment by otolaryngology and maxillofacial surgery teams versus non-combined approaches, and to evaluate whether the type of prior treatment influences the need for reintervention or secondary procedures. Methods: We conducted a retrospective observational study including 96 patients with ODS surgically treated between January 2019 and December 2024. Patients were categorized according to etiology and surgical strategy (combined vs. non-combined). Additionally, we analyzed whether the type of previous treatment (none, otolaryngology alone, maxillofacial surgery, dentist, or combined) was associated with the need for reoperation or second-stage maxillofacial surgery. Results: Combined surgery significantly reduced reoperation rates (p = 0.003), particularly in periodontic/endodontic infection cases (p = 0.002). No significant differences were observed in the need for second-stage maxillofacial surgery between groups. Reoperation was more frequent among patients initially treated by otolaryngology or maxillofacial surgeons, while those managed first by dentists had significantly lower reoperation rates (p < 0.001). The type of previous treatment was not significantly associated with second-stage maxillofacial surgery. Etiology and patient age did not influence surgical outcomes. Conclusion: Single-stage combined surgery reduces the need for reoperation in ODS. When a staged approach is selected, prioritizing initial dental or maxillofacial management before otolaryngologic intervention appears to yield better outcomes.
7 June 2025 in Indian Journal of Otolaryngology and Head & Neck Surgery
Primary extranodal non-Hodgkin lymphoma (PE-NHL) of the head and neck is rare and often presents with nonspecific symptoms, delaying diagnosis. We report a 75-year-old woman with persistent hoarseness diagnosed with a follicular lymphoma in the larynx. Early biopsy and staging are crucial for timely treatment, improving prognosis in atypical presentations.
Background and Objectives: Graves’ orbitopathy (GO) is an autoimmune disease that can cause severe visual dysfunction and cosmetic impairment. Pure endoscopic orbital decompression reduces proptosis with minimal external morbidity. However, studies integrating both objective outcomes and patient-reported quality of life remain limited. This study aimed to analyze objective and subjective outcomes of pure endoscopic orbital decompression in inactive GO. Materials and Methods: We retrospectively reviewed 20 consecutive patients with severe inactive GO who underwent pure endoscopic transnasal orbital decompression between 2020 and 2023. Proptosis was measured using Hertel exophthalmometry, and quality of life was assessed with the disease-specific GO-QoL (Graves’ Ophthalmopathy Quality of Life) questionnaire (functional and appearance subscales). Minimum follow-up was 12 months. Pre- and postoperative changes were compared using paired t tests. Results: A total of 26 orbits were operated on. Mean proptosis decreased by 3.85 mm (p < 0.001). GO-QoL improved in the functional (+3.27, p < 0.001) and appearance (+5.77, p < 0.001) subscales. No complications or new/worsened diplopia were observed. Conclusions: Pure endoscopic orbital decompression is a safe and effective technique to reduce proptosis in inactive GO. Although quality-of-life scores improved significantly, the clinical relevance may vary, highlighting the need to integrate objective outcomes and patient perception when evaluating surgical results.
Purpose Hereditary haemorrhagic telangiectasia (HHT) is frequently associated with recurrent epistaxis, causing morbidity and impaired quality of life. Data on operating room-based endonasal polidocanol sclerotherapy remain limited. This study aimed to assess the effectiveness, safety, patient acceptance, and procedural feasibility of this approach for HHT-related epistaxis. Methods A retrospective observational study was conducted in a tertiary referral centre including 20 adults with HHT treated with endonasal polidocanol sclerotherapy between March 2022 and December 2025. Clinical variables, visceral arteriovenous malformation (AVM) involvement, procedure-related variables, complications, and patient-reported outcomes were analysed. Results A total of 59 procedures were performed. Mean weekly epistaxis frequency decreased from 8.3 to 2.35 episodes per week (p < 0.001), with a mean relative reduction of 68.1% and an effect size of 1.27. Seventeen patients (85%) met responder criteria, defined as a reduction of at least 50% in weekly epistaxis frequency compared with baseline. Fourteen patients (70%) presented visceral AVM involvement, and 35% had high-burden disease. Severe epistaxis episodes requiring hospital-based care showed a non-significant numerical decrease. Two patients (10%) experienced complications, one requiring hospital admission. Nineteen patients (95%) reported willingness to undergo the procedure again. Conclusion Operating room endonasal polidocanol sclerotherapy was associated with clinically meaningful reduction in epistaxis burden, high patient acceptance, and a favourable safety profile. This approach may represent a valuable option for selected patients with recurrent HHT-related epistaxis requiring structured management beyond an office-based setting.
About Me
Otorhinolaryngologist-Head & Neck Surgeon Resident. General Surgeon. PhD Student at University of Valencia.
Otorhinolaryngologist-Head & Neck Surgeon Resident. General Surgeon. PhD Student at University of Valencia.